{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:54:57Z","timestamp":1790384097592,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.clon.2020.07.007","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T02:27:26Z","timestamp":1595557646000},"page":"40-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Long-term Survival Outcomes of \u2018Low Risk\u2019 Ductal Carcinoma in situ from a Territory-wide Cancer Registry"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1705-051X","authenticated-orcid":false,"given":"M.","family":"Co","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.K.C.","family":"Ngan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.W.K.","family":"Mang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2496-9145","authenticated-orcid":false,"given":"A.H.P.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.H.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2020.07.007_bib1","series-title":"Cancer of the breast","article-title":"In situ carcinoma of the breast","author":"Silverstein","year":"2002"},{"issue":"12","key":"10.1016\/j.clon.2020.07.007_bib2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jama.1996.03530360023033","article-title":"Incidence of and treatment for ductal carcinoma in situ of the breast","volume":"275","author":"Ernster","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.clon.2020.07.007_bib3","series-title":"SEER cancer statistics review, 1975\u20132017","author":"Howlader","year":"2017"},{"key":"10.1016\/j.clon.2020.07.007_bib4","series-title":"Breast cancer epidemiology","first-page":"47","article-title":"In situ breast cancer","author":"Sprague","year":"2010"},{"issue":"3","key":"10.1016\/j.clon.2020.07.007_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnci\/djp485","article-title":"National Institutes of Health state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ September 22\u201324, 2009","volume":"102","author":"Allegra","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clon.2020.07.007_bib6","first-page":"17","article-title":"Ductal carcinoma in situ of the breast \u2013 long term results from a twenty-year cohort","volume":"14","author":"Co","year":"2018","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.clon.2020.07.007_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.clon.2020.07.007_bib8","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<616::AID-CNCR12>3.0.CO;2-7","article-title":"Predictors of local recurrence after treatment of ductal carcinoma in situ: a metaanalysis","volume":"85","author":"Boyages","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2020.07.007_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-005-9101-z","article-title":"The natural history of ductal carcinoma in situ of the breast: a review","volume":"97","author":"Erbas","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.clon.2020.07.007_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv372","article-title":"Outcomes of active surveillance for ductal carcinoma in situ: a computational risk analysis","volume":"108","author":"Ryser","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.clon.2020.07.007_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamasurg.2015.0876","article-title":"Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study","volume":"150","author":"Sagara","year":"2015","journal-title":"JAMA Surg"},{"issue":"16","key":"10.1016\/j.clon.2020.07.007_bib12","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.clon.2020.07.007_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2020.07.007_bib14","doi-asserted-by":"crossref","first-page":"m1570","DOI":"10.1136\/bmj.m1570","article-title":"Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988\u20132014: population based observational cohort study","volume":"369","author":"Mannu","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.clon.2020.07.007_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2018.06.027","article-title":"Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane project","volume":"101","author":"Thompson","year":"2018","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.clon.2020.07.007_bib16","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1186\/s12885-017-3808-1","article-title":"Prevalence of incidental breast cancer and precursor lesions in autopsy studies: a systematic review and meta-analysis","volume":"17","author":"Thomas","year":"2017","journal-title":"BMC Cancer"},{"issue":"33","key":"10.1016\/j.clon.2020.07.007_bib17","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","article-title":"Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study","volume":"33","author":"Solin","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2020.07.007_bib18","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/1097-0142(19930315)71:6<2020::AID-CNCR2820710616>3.0.CO;2-#","article-title":"Mammographic assessment of human breast cancer growth and duration","volume":"71","author":"Spratt","year":"1993","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.clon.2020.07.007_bib19","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ \u2013 the LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.clon.2020.07.007_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The Comparison of Operative versus Monitoring and Endocrine Therapy trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.clon.2020.07.007_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiology.218.2.r01fe35497","article-title":"Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates","volume":"218","author":"Jackman","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.clon.2020.07.007_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5858\/2002-126-0039-PIITES","article-title":"Predicting invasion in the excision specimen from breast core needle biopsy specimens with only ductal carcinoma in situ","volume":"126","author":"Renshaw","year":"2002","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.clon.2020.07.007_bib23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12282-009-0164-2","article-title":"The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ","volume":"17","author":"Hung","year":"2010","journal-title":"Breast Cancer"},{"key":"10.1016\/j.clon.2020.07.007_bib24","series-title":"Ductal carcinoma in situ of the breasts - over-diagnosis, over-treatment and a decade of lost direction","author":"Co","year":"2020"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655520302892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655520302892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:48:19Z","timestamp":1760543299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655520302892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0936655520302892"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2020.07.007","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Survival Outcomes of \u2018Low Risk\u2019 Ductal Carcinoma in situ from a Territory-wide Cancer Registry","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2020.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}]}}